亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

上海永恒生物科技有限公司  

中藥標準品,中藥單體,中藥提出物,中藥新藥開發

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:顧正兵
  • 電話:021-69734790
  • 郵件:zbg@forever-biotech.com
  • 傳真:021-69734790
  • QQ:646670394
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 白射干素,野鳶尾苷,鳶尾苷元
白射干素,野鳶尾苷,鳶尾苷元
單價 面議對比
詢價 暫無
發貨 上海付款后3天內
純度 ≥98.5%
規格 10mg 20mg 1g
用途 含量測定,藥理試劑
過期 長期有效
更新 2015-01-05 09:28
 
詳細信息
 白射干素 Dichotomitin;5,3'-Dihydroxy-4',5'-dimethoxy-6,7-methylenedioxyisoflavone
                88509-91-5   C18H14O8  358.30   ≥98.5

野鳶尾苷 Irigenin-7-O-beta-D-glucopyranoside   491-74-7   C24H26O13   522.46    ≥98.5

鳶尾苷元 Tectorigenin;Tectrigenin   548-77-6   C16H12O6   300.26   ≥98.0

本公司是科研試劑產品專業研發及生產企業之一,擁有長達10年以上的試劑產品研發及生產經驗。嚴格的質量控制體系,保證產品的質量,價格更優惠,請您放心購買!

©2025 上海永恒生物科技有限公司 版權所有   技術支持:化工網   訪問量:22378  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |